Redox Dysregulation in the Pathophysiology of Schizophrenia and Bipolar Disorder: Insights from Animal Models-Reference-Cited by-同舟云学术

Redox Dysregulation in the Pathophysiology of Schizophrenia and Bipolar Disorder: Insights from Animal Models

Published:2013-04-20 Issue:12 Volume:18 Page:1428-1443
ISSN:1523-0864
Container-title:Antioxidants & Redox Signaling
language:en
Short-container-title:Antioxidants & Redox Signaling

Author:

Kulak Anita¹,Steullet Pascal¹,Cabungcal Jan-Harry¹,Werge Thomas²,Ingason Andrés²,Cuenod Michel¹,Do Kim Quang¹

Affiliation:

1. Department of Psychiatry, Center for Psychiatric Neuroscience, Lausanne University Hospital, Prilly-Lausanne, Switzerland.

2. Mental Health Centre Sct. Hans, Research Institute of Biological Psychiatry, Copenhagen University Hospital, Roskilde, Denmark.

Publisher

Mary Ann Liebert Inc

Subject

Cell Biology,Clinical Biochemistry,Molecular Biology,Physiology,Biochemistry,Cell Biology,Clinical Biochemistry,Molecular Biology,Physiology,Biochemistry

Link

http://www.liebertpub.com/doi/pdf/10.1089/ars.2012.4858

Reference130 articles.

1. Modulation of neuronal and recombinant GABA A receptors by redox reagents

2. Oxidative stress markers in bipolar disorder: A meta-analysis

3. Ventral hippocampal lesions affect anxiety but not spatial learning

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increased Parenchymal Macrophages are associated with decreased Tyrosine Hydroxylase mRNA levels in the Substantia Nigra of people with Schizophrenia and Bipolar Disorder;Psychiatry Research;2024-10

2. The Pathophysiological Underpinnings of Gamma-Band Alterations in Psychiatric Disorders;Life;2024-04-30

3. Sleep, mood disorders, and the ketogenic diet: potential therapeutic targets for bipolar disorder and schizophrenia;Frontiers in Psychiatry;2024-02-14

4. Druggable causal genes of bipolar disorder identified through Mendelian Randomization analysis offer a route to intervention in integrated stress response;2023-12-21

5. Therapeutic potential of NOX inhibitors in neuropsychiatric disorders;Psychopharmacology;2023-07-28